|
Epigenetic and microenvironmental regulation of dormant disseminated cancer
|
5R01CA218024-02
|
$428,136
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Post-translational control of cancer cell stress response and metastasis
|
5R01CA202027-03
|
$459,505
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-06
|
$238,147
|
$14,289
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Immuno/Immunogene Therapies for Thoracic Malignancies
|
5P01CA066726-13
|
$1,203,367
|
$601,684
|
Albelda, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
|
5R01CA178610-05
|
$317,240
|
|
ALUMKAL, JOSHI
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence
|
5R01CA208042-03
|
$363,713
|
|
ALVAREZ, JAMES
|
DUKE UNIVERSITY
|
|
Role of Splicing Factors in Breast Cancer
|
5R00CA178206-05
|
$249,000
|
|
ANCZUKOW-CAMARDA, OLGA
|
JACKSON LABORATORY
|
|
Sensitization to CD47 Blockade to Enhance Anti-Tumor Immunity
|
5F30CA195973-04
|
$49,524
|
|
ANDERSON, KATIE
|
UNIVERSITY OF MINNESOTA
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-26
|
$301,545
|
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
Elucidating transcription regulation by epigenetics in neuroblastoma
|
1K08CA226237-01
|
$206,394
|
|
APPLEBAUM, MARK
|
UNIVERSITY OF CHICAGO
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$483,295
|
$120,824
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$7,852
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
|
5R35CA197591-04
|
$977,640
|
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-35
|
$417,370
|
$25,042
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Development of a New Generation Micro-CT imaging for Functional and Molecular Imaging of Cancer
|
5R01CA196667-04
|
$521,837
|
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-19
|
$687,330
|
$13,747
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
Southwest Oncology Group
|
5U10CA027057-30
|
$267,015
|
$2,670
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-30
|
$9,379,270
|
$93,793
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-25
|
$10,708,109
|
$107,081
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Understanding the Mechanism of a Gut Microbial Genotoxin Involved in Colorectal Carcinogenesis
|
5R01CA208834-03
|
$383,091
|
|
BALSKUS, EMILY
|
HARVARD UNIVERSITY
|
|
Growth Control in Multiple Myeloma
|
2P01CA055819-15
|
$3,715,800
|
$371,580
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
Growth Control in Multiple Myeloma
|
3P01CA055819-14S1
|
$849,984
|
$84,998
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
Postdoctoral Research Training in Biotherapy of Cancer
|
2T32CA113263-11
|
$193,203
|
|
BARTLETT, DAVID
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer
|
5U01CA202958-03
|
$668,427
|
|
BASANTA GUTIERREZ, DAVID
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Novel Roles for Oncogenic SOX2 in Esophageal Squamous Cell Carcinoma
|
5R01CA187119-04
|
$384,872
|
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Targeted Radiation Therapy for Pancreatic Cancer
|
5R01CA195586-04
|
$435,945
|
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
High Sensitivity Detection of Mutant cf-ctDNA with DNA-Guided Argonaut Enzymes
|
1R21CA227056-01
|
$210,105
|
|
BAU, HAIM
|
UNIVERSITY OF PENNSYLVANIA
|
|
Targeting macrophages for immunotherapy in pancreatic cancer
|
5R01CA197916-03
|
$368,288
|
|
BEATTY, GREGORY
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Gulf Coast MBCCOP
|
5U10CA128536-03
|
$507,986
|
$5,080
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
Iowa Oncology Research Association
|
5U10CA035101-24
|
$865,544
|
$8,655
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
The role of Toll-like receptor 3 in overcoming cancer immunoediting
|
5K22CA122828-03
|
$162,035
|
$40,509
|
Bell, Jessica
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Ovarian Cancer Chemoprevention
|
5R01CA196200-04
|
$465,809
|
|
BENBROOK, DORIS
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Targeting HPV Consequences in a Cervical Cancer Clinical Trial
|
5R01CA200126-03
|
$176,894
|
|
BENBROOK, DORIS
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Eastern Cooperative Oncology Group Clinical Trials
|
5U10CA017145-34
|
$460,085
|
$27,605
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$735
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$590
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$846
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$68,965
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Devaluing Energy-Dense Foods for Cancer Control: Translational Neuroscience
|
5R01CA211224-02
|
$705,027
|
|
BERKMAN, ELLIOT
|
UNIVERSITY OF OREGON
|
|
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
|
5R01CA197359-04
|
$388,875
|
|
BERLIN, JACOB
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-26
|
$610,000
|
$6,100
|
Bernath, Albert
|
WEIS CENTER FOR RESEARCH-GEISINGER CLINC
|
|
Deciphering the tumor suppressive functions of macroH2A
|
5R01CA154683-07
|
$436,463
|
|
BERNSTEIN, EMILY
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas
|
5R01CA219943-02
|
$507,552
|
|
BEROUKHIM, RAMEEN
|
BROAD INSTITUTE, INC.
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,020,404
|
$202,040
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Matrix metalloproteinase-2 modulates inflammation via TLR2
|
5R01CA180913-05
|
$351,713
|
|
BHARDWAJ, NINA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
NK cell exhaustion in metastatic melanoma
|
5R01CA201189-03
|
$387,731
|
|
BHARDWAJ, NINA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
|
5R01CA204924-03
|
$657,305
|
|
BLASBERG, RONALD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Prostate Cancer Susceptibility Gene Identification in Chromosome 5 Candidate Region
|
1R21CA220311-01A1
|
$178,029
|
|
BOCK, CATHRYN
|
WAYNE STATE UNIVERSITY
|
|
RPRD1B/Kub5/Hera, an RNA Pol II determinant that controls PARPi & IR sensitivity
|
5R01CA210489-04
|
$360,281
|
|
BOOTHMAN, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Defining and translating the properties that sustain the antitumor efficacy of Th17 cells
|
5F30CA200272-04
|
$46,154
|
|
BOWERS, JACOB
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
Total relevant funding to Interferon for this search: $15,096,924
|